J Osma1, A Quilez-Orden2, C Suso-Ribera3, O Peris-Baquero4, S B Norman5, K H Bentley6, S Sauer-Zavala7. 1. Universidad de Zaragoza, Zaragoza, Spain; Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain. Electronic address: osma@unizar.es. 2. Universidad de Zaragoza, Zaragoza, Spain. 3. Universitat Jaume I, Castellón, Spain. 4. Instituto de Investigación Sanitaria de Aragón, Zaragoza, Spain. 5. National Center for PTSD, Vermont, USA; University of California, San Diego, USA; VA San Diego Healthcare System, USA. 6. Department of Psychiatry, Massachusetts General Hospital/Harvard Medical School, USA. 7. Center for Anxiety and Related Disorders, Boston University, USA.
Abstract
BACKGROUND: Anxiety and depressive disorders are the most frequent disorders for which patients seek care in public health settings in Spain. This study aimed at validating the Overall Anxiety Severity and Impairment Scale (OASIS) and the Overall Depression Severity and Impairment Scale (ODSIS), which are brief screening scales for anxiety and depression consisting of only five items each. METHODS: The study was conducted in a Spanish clinical sample receiving outpatient mental health treatment (N = 339). A subsample of participants (n = 219) was assessed before and after receiving a course of cognitive-behavioral treatment. RESULTS: The results revealed excellent internal consistency estimates (Cronbach's alpha for the OASIS and the ODSIS was 0.87 and 0.94, respectively), along with promising convergent and discriminant validity and test-criterion relationships (i.e., moderate correlation with other measures of depression and anxiety, as well as with neuroticism, quality of life, adjustment, and negative affect). A one-dimensional structure was obtained for the OASIS and the ODSIS. The ROC analyses indicated an area under the curve of 0.83 for the OASIS and the ODSIS when predicting moderate-to-severe anxiety and depression, respectively. Good sensitivity to therapeutic change was also evidence and the analysis of the sensitivity as a function of 1-specificity area suggested a cutoff value of 10 for both scales. LIMITATIONS: Inter-rater reliability of diagnoses with the ADIS-IV interview could not be investigated and the results obtained may not be generalizable to other samples and health settings. CONCLUSIONS: The availability of these two short and psychometrically sound measures should make screening of anxiety and depressive symptoms in routine care more feasible.
BACKGROUND:Anxiety and depressive disorders are the most frequent disorders for which patients seek care in public health settings in Spain. This study aimed at validating the Overall Anxiety Severity and Impairment Scale (OASIS) and the Overall Depression Severity and Impairment Scale (ODSIS), which are brief screening scales for anxiety and depression consisting of only five items each. METHODS: The study was conducted in a Spanish clinical sample receiving outpatient mental health treatment (N = 339). A subsample of participants (n = 219) was assessed before and after receiving a course of cognitive-behavioral treatment. RESULTS: The results revealed excellent internal consistency estimates (Cronbach's alpha for the OASIS and the ODSIS was 0.87 and 0.94, respectively), along with promising convergent and discriminant validity and test-criterion relationships (i.e., moderate correlation with other measures of depression and anxiety, as well as with neuroticism, quality of life, adjustment, and negative affect). A one-dimensional structure was obtained for the OASIS and the ODSIS. The ROC analyses indicated an area under the curve of 0.83 for the OASIS and the ODSIS when predicting moderate-to-severe anxiety and depression, respectively. Good sensitivity to therapeutic change was also evidence and the analysis of the sensitivity as a function of 1-specificity area suggested a cutoff value of 10 for both scales. LIMITATIONS: Inter-rater reliability of diagnoses with the ADIS-IV interview could not be investigated and the results obtained may not be generalizable to other samples and health settings. CONCLUSIONS: The availability of these two short and psychometrically sound measures should make screening of anxiety and depressive symptoms in routine care more feasible.
Authors: Jonathan S Comer; Kristina Conroy; Danielle Cornacchio; Jami M Furr; Sonya B Norman; Murray B Stein Journal: J Affect Disord Date: 2021-12-31 Impact factor: 6.533
Authors: J Osma; Laura Martínez-García; Óscar Peris-Baquero; María Vicenta Navarro-Haro; Alberto González-Pérez; Carlos Suso-Ribera Journal: BMJ Open Date: 2021-12-31 Impact factor: 2.692
Authors: Jorge Osma; Víctor Martínez-Loredo; Amanda Díaz-García; Alba Quilez-Orden; Óscar Peris-Baquero Journal: Int J Environ Res Public Health Date: 2021-12-29 Impact factor: 3.390
Authors: Anabel de la Rosa-Gómez; Lorena A Flores-Plata; Esteban E Esquivel-Santoveña; Carolina Santillán Torres Torija; Raquel García-Flores; Alejandro Dominguez-Rodriguez; Paulina Arenas-Landgrave; Rosa O Castellanos-Vargas; Enrique Berra-Ruiz; Rocío Silvestre-Ramírez; Germán Alejandro Miranda-Díaz; Dulce M Díaz-Sosa; Alejandrina Hernández-Posadas; Alicia I Flores-Elvira; Pablo D Valencia; Mario F Vázquez-Sánchez Journal: BMC Psychiatry Date: 2022-08-09 Impact factor: 4.144